Benefit-Risk Appraisal Of Medicines : for every new medicine. the ability to assess...

Benefit-Risk Appraisal of Medicines : the approval process for every new medicine. the

Benefit-Risk Appraisal of Medicines ability to assess the risks of a new medicine accurately and to balance these...

Author : Filip Mussen

medicine accurately and to balance these against the benefits the medicine could bring is

Publisher : John Wiley & Sons

benefits the medicine could bring is critical for every regulatory authority and pharmaceutical company.

0470748125

ISBN

0470748125

isbn_13

and pharmaceutical company. Despite this there are very few tried and tested evaluative models

Download File Read Full Now
Benefit-Risk Assessment Of Medicines : documentation system, to facilitate and...

Benefit-Risk Assessment of Medicines : framework, and accompanying documentation system,

Benefit-Risk Assessment of Medicines catalogue benefit-risk decisions; a valuable addition to the benefit-risk toolbox. Over the past...

Author : James Leong

benefit-risk toolbox. Over the past decade, pharmaceutical companies and regulatory agencies have been

Publisher : Springer

and regulatory agencies have been reviewing the benefit-risk assessment of medicines with a

3319158058

ISBN

3319158058

isbn_13

with a view to developing a structured, systematic, standardized approach. Examining the evaluation

Download File Read Full Now
Benefit-Risk Assessment In Pharmaceutical Research And Development : with benefit-risk assessment, despite its...

Benefit-Risk Assessment in Pharmaceutical Research and Development : still largely unfamiliar with benefit-risk

Benefit-Risk Assessment in Pharmaceutical Research and Development growing prominence in drug development and commercialization. Helping to alleviate this knowledge gap, Benefit-Risk Assessment in...

Author : Andreas Sashegyi

to alleviate this knowledge gap, Benefit-Risk Assessment in Pharmaceutical Research and Development provides a succinct overview

Publisher : CRC Press

Pharmaceutical Research and Development provides a succinct overview of the key considerations relevant to benefit-risk assessment

143986795X

ISBN

143986795X

isbn_13

considerations relevant to benefit-risk assessment across the pharmaceutical R&D spectrum, from early clinical development to late-stage

Download File Read Full Now
Quantitative Decisions In Drug Development : drug development. because of the inseparable relationship between...

Quantitative Decisions in Drug Development : evidence-based decisions in drug development. because of the

Quantitative Decisions in Drug Development inseparable relationship between designs and decisions, a good portion of this...

Author : Christy Chuang-Stein

portion of this book is devoted to the design of clinical

Publisher : Springer

design of clinical trials. The book begins with an overview of

3319460765

ISBN

3319460765

isbn_13

product development and regulatory approval pathways. It then discusses how to

Download File Read Full Now
The Benefit/Risk Ratio : diseases has a long tradition; however, it...

The Benefit/Risk Ratio : various types of diseases has a long

The Benefit/Risk Ratio however, it has only been recently recognized that the value of...

Author : Hans C. Korting

the value of any given compound must be evaluated in light

Publisher : CRC Press

evaluated in light of its benefit to risk ratio. When prescribing

9781439805916

ISBN

9781439805916

isbn_13

drugs, physicians must look at the big picture of the drug's

Download File Read Full Now
Decision Making In Health And Medicine : and values / m.g. myriam...

Decision Making in Health and Medicine : medicine: integrating evidence and values

Decision Making in Health and Medicine Hunink ... [et al.]. 2001....

Author : M. G. Myriam Hunink

Publisher : Cambridge University Press

1107690471

ISBN

1107690471

isbn_13


Download File Read Full Now
The Perception And Management Of Drug Safety Risks : consists of twenty-four articles authored by...

The Perception and management of drug safety risks : of robert gilmer, consists of twenty-four

The Perception and management of drug safety risks by his most prominent students and followers. These articles combine surveys of past work by Gilmer and...

Author : Bruno Horisberger

articles combine surveys of past work by Gilmer and others, recent results which have never before seen

Publisher : Springer

and others, recent results which have never before seen print, open problems, and extensive bibliographies. The entire

9780387505343

ISBN

9780387505343

isbn_13

problems, and extensive bibliographies. The entire collection provides an in-depth overview of the topics of research in

Download File Read Full Now
Improving Drug Safety — A Joint Responsibility : their cost and effectiveness to their real and...

Improving Drug Safety — A Joint Responsibility : from concern for their cost and effectiveness to

Improving Drug Safety — A Joint Responsibility their real and potential risks and benefits, a critical question has been raised: whose...

Author : Rolf Dinkel

critical question has been raised: whose responsibility is it to improve drug safety? In

Publisher : Springer Science & Business Media

it to improve drug safety? In April 1990, this question became the theme for

3642612504

ISBN

3642612504

isbn_13

the theme for a conference at Wolfsberg, Switzerland, near the shores of Lake Constance.

Download File Read Full Now
Strategic Project Risk Appraisal And Management : the right thing' (choosing the right projects)...

Strategic Project Risk Appraisal and Management : management skills: 'doing the right thing' (choosing

Strategic Project Risk Appraisal and Management right projects) and 'doing things right' (good project management). This book examines the challenges...

Author : Professor Elaine Harris

management). This book examines the challenges that managers face in assessing the likely risks

Publisher : Gower Publishing, Ltd.

face in assessing the likely risks and benefits that need to be taken into

1409458601

ISBN

1409458601

isbn_13

be taken into account when choosing projects. It then explores the strategic level risks

Download File Read Full Now
Targeted Therapies In Cancer : selectivity because antiproliferative drugs are often...

Targeted Therapies in Cancer : encumbered by poor selectivity because antiproliferative

Targeted Therapies in Cancer often toxic not only to tumor cells but also to important populations of the body’s non-neoplastic...

Author : Manfred Dietel

also to important populations of the body’s non-neoplastic cells. Modern targeted therapies interact with defined molecules

Publisher : Springer Science & Business Media

cells. Modern targeted therapies interact with defined molecules present on cancer cells, adding increased selectivity to

3540460918

ISBN

3540460918

isbn_13

cells, adding increased selectivity to their toxic effects. This book presents an integrated critical view on

Download File Read Full Now
Clinical Pharmacology : if drugs are to be...

Clinical Pharmacology : principles is vital if drugs

Clinical Pharmacology used safely and effectively for increasingly informed patients. Those who clearly...

Author : Morris J. Brown

Those who clearly understand how drugs get into the body, how

Publisher : Elsevier Health Sciences

the body, how they produce their effects, what happens to them

0702051136

ISBN

0702051136

isbn_13

in the body, and how evidence of their therapeutic effect is

Download File Read Full Now
Seafood Choices : and health risks associated with fish...

Seafood Choices : the nutritional value and health risks

Seafood Choices fish and shellfish can result in confusion or misperceptions about these...

Author : Institute of Medicine

misperceptions about these food sources. Consumers are therefore confronted with a

Publisher : National Academies Press

confronted with a dilemma: they are told that seafood is good

0309102189

ISBN

0309102189

isbn_13

for them and should be consumed in large amounts, while at

Download File Read Full Now